IHT Wealth Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,197
Closed -$5.58K 1040
2023
Q2
$5.58K Buy
+1,197
New +$5.86K ﹤0.01% 967
2022
Q4
Sell
-197
Closed -$4K 957
2022
Q3
$4K Hold
197
﹤0.01% 867
2022
Q2
$10K Hold
197
﹤0.01% 731
2022
Q1
$28K Buy
197
+17
+9% +$2.48K ﹤0.01% 752
2021
Q4
$31K Hold
180
﹤0.01% 795
2021
Q3
$90K Hold
180
0.01% 777
2021
Q2
$90K Buy
180
+33
+22% +$17.7K 0.01% 916
2021
Q1
$74K Buy
147
+10
+7% +$5.16K 0.01% 814
2020
Q4
$65K Buy
137
+17
+14% +$5.58K 0.01% 729
2020
Q3
$34K Buy
+120
New +$29.7K ﹤0.01% 655
2020
Q2
Sell
-56
Closed -$7K 652
2020
Q1
$7K Buy
+56
New +$10.1K ﹤0.01% 554
2019
Q4
Sell
-56
Closed -$8K 656
2019
Q3
$8K Hold
56
﹤0.01% 610
2019
Q2
$6K Buy
+56
New +$8.87K ﹤0.01% 545

Other funds holding AMPE

IHT Wealth Management's AMPE Position: Q3 2023 in Review

IHT Wealth Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2023, closing a stake of 1,197 shares — an estimated $5.58K sold.

IHT Wealth Management first reported a position in AMPE in Q2 2019 and held it in 13 quarters. The position peaked at $90K in Q3 2021. 26 funds tracked by Wall St. Rank hold AMPE as of Q3 2023.

  • IHT Wealth Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2023 after selling out during the quarter.
  • IHT Wealth Management sold 1,197 Ampio Pharmaceuticals Inc. shares in Q3 2023, an estimated $5.58K.
  • IHT Wealth Management first reported a position in Ampio Pharmaceuticals Inc. in Q2 2019 and held it in 13 quarters.
  • IHT Wealth Management's Ampio Pharmaceuticals Inc. position peaked at $90K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2023.

Based on IHT Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.